» Articles » PMID: 3758144

Potential Pulmonary Uptake and Clearance of Morphine in Postoperative Patients

Overview
Specialty Pharmacology
Date 1986 Jan 1
PMID 3758144
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The influence of lung uptake and lung clearance on the disposition of morphine was studied in surgical patients. In the postoperative period morphine was given intravenously by a two-rate infusion regimen. Under steady-state conditions samples of mixed central venous blood (pulmonary artery) and peripheral arterial blood (radial artery) were taken simultaneously and at the same time cardiac output was measured. The concentration differences between venous and arterial blood were used to calculate the extraction ratio of morphine across the lung. In all patients there was marked pulmonary uptake, but the concentration differences in most of them were small under steady-state conditions. The extraction ratio (mean +/- SD) across the lung was 0.06 +/- 0.10, implying insignificant lung clearance. However, in two patients, both with diabetes mellitus, there was a significant concentration gradient, indicating that the lung could contribute to the total body elimination of morphine. On the other hand, the total clearance was similar in diabetic and nondiabetic patients (1190 and 1150 ml/min, respectively), implying that pulmonary clearance would have no significant influence on the kinetics of morphine. A physiologically based pharmacokinetic model was used to describe the disposition of morphine in post-operative patients. The model allowed simulation of pulmonary diffusion, uptake and elimination and supported conclusions based on model-independent experimental data.

Citing Articles

Pulmonary disposition of pethidine in postoperative patients.

Persson M, Hartvig P, Wiklund L, PAALZOW L Br J Clin Pharmacol. 1988; 25(2):235-41.

PMID: 3358885 PMC: 1386479. DOI: 10.1111/j.1365-2125.1988.tb03296.x.


The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Bodenham A, Shelly M, Park G Clin Pharmacokinet. 1988; 14(6):347-73.

PMID: 3293870 DOI: 10.2165/00003088-198814060-00003.


The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.

Hoskin P, Hanks G, Aherne G, Chapman D, Littleton P, Filshie J Br J Clin Pharmacol. 1989; 27(4):499-505.

PMID: 2719903 PMC: 1379730. DOI: 10.1111/j.1365-2125.1989.tb05399.x.


The effect of respiratory disorders on clinical pharmacokinetic variables.

Taburet A, Tollier C, Richard C Clin Pharmacokinet. 1990; 19(6):462-90.

PMID: 2292169 DOI: 10.2165/00003088-199019060-00004.


The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.

Milne R, Nation R, Somogyi A, Bochner F, Griggs W Br J Clin Pharmacol. 1992; 34(1):53-9.

PMID: 1633068 PMC: 1381375. DOI: 10.1111/j.1365-2125.1992.tb04107.x.

References
1.
Paalzow L . Pharmacokinetic aspects of optimal pain treatment. Acta Anaesthesiol Scand Suppl. 1982; 74:37-43. DOI: 10.1111/j.1399-6576.1982.tb01843.x. View

2.
Berkowitz B, NGAI S, Yang J, Hempstead J, Spector S . The diposi tion of morphine in surgical patients. Clin Pharmacol Ther. 1975; 17(6):629-35. DOI: 10.1002/cpt1975176629. View

3.
Collins J, Dedrick R . Contribution of lungs to total body clearance: linear and nonlinear effects. J Pharm Sci. 1982; 71(1):66-70. DOI: 10.1002/jps.2600710117. View

4.
Owen J, Sitar D, Berger L, Brownell L, Duke P, Mitenko P . Age-related morphine kinetics. Clin Pharmacol Ther. 1983; 34(3):364-8. DOI: 10.1038/clpt.1983.180. View

5.
Davis M, Mehendale H . Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung. Drug Metab Dispos. 1979; 7(6):425-8. View